Formulations for clinical trials and beyond
Budget is often scarce for pharmaceutical development projects before the drug has even shown proof of concept in first clinical trials. In that early stage, many drug developing companies are hesitant to spend the money for a fully-fledged pharmaceutical development of the formulation. Thus, quite often formulations in preclinical studies and clinical stages I and […]